Treating sleep disorders

Size: px
Start display at page:

Download "Treating sleep disorders"

Transcription

1 Treating sleep disorders Sue Wilson Centre for Neuropsychopharmacology Imperial College London

2 Suggested algorithm for treatment of insomnia Diagnosis of insomnia Associated with another disorder no Significant distress and daytime symptoms in spite of good sleep habits yes Ensure other disorder is adequately treated Insomnia persists Likely to resolve soon (eg bereavement, short term stressor etc) CBTi Availability? Availability? After CBTi After CBTi no Offer (patient choice) CBTi Hypnotic drug Hypnotic drug Review Review Z drug Z drug PR melatonin if over 55 In 4 weeks yes - Consider 3-7 days of Z drug British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders J Psychopharm (2010) 24(11) Improved? Open appointment Not improved Reassess Refer Consider alternative medication

3 Which elements of cognitive behavioural therapy for insomnia (CBTi) have a good evidence base 1 Sleep hygiene 2 Psychodynamic psychotherapy 3 Sleep restriction and stimulus control 4 Mindfulness 5 Relaxation

4 Cognitive behavioural therapy for insomnia (CBTi) Very good evidence base for multicomponent CBTi May last longer than pharmacological treatment Can be individual or group-based, also online Multicomponent, usual elements are *Sleep scheduling and bedtime restriction Stimulus control *Addressing dysfunctional attitudes and beliefs about sleep Relaxation/exercise Sometimes mindfulness-based stress reduction (* current evidence for these components very good) HOWEVER many patients do not choose this option

5 Which of these pharmacological treatments often used for chronic insomnia have a good evidence base? 1 Melatonin 2 Benzodiazepine receptor agonists 3 Histamine H1 receptor antagonists 4 Serotonin and noradrenaline reuptake inhibitors with tricyclic structure used in depression (eg amitriptyline) 5 Dopamine and serotonin antagonists used in psychosis (eg quetiapine)

6 Drugs used in insomnia Licensed for insomnia GABA-A positive allosteric modulators (benzodiazepine receptor agonists and chloral etc) melatonin (modified release) for older adults promethazine diphenhydramine doxepin (USA) suvorexant (USA) Unlicensed prescribed frequently Histamine H1 antagonists (and OTC) Older drugs for depression Sometimes prescribed Drugs for psychosis

7 Which of these drugs are benzodiazepine receptor agonists? (ie effects reversed by the antagonist flumazenil) 1.Temazepam 2. Zopiclone 3. Clonazepam 4. Chloral hydrate 5. Zolpidem

8 Some GABA-A positive allosteric modulators Drugs acting at the GABA-A benzodiazepine receptor zopiclone zolpidem zaleplon benzodiazepines eg temazepam, lorazepam (safe in overdose, as long as no other drug involved; effects reversed by flumazenil) Drugs acting at the barbiturate/alcohol receptor chloral hydrate/chloral betaine clomethiazole (dangerous in overdose)

9 Effects of GABA-A positive allosteric modulators These drugs enhance the effect of GABA, the main inhibitory neurotransmitter in the brain They all produce sedation, sleep promotion, ataxia, muscle relaxation, effects on memory, anticonvulsant effects For insomnia, these effects are unwanted during the day, therefore the duration of action of the drug is important

10 Which is the shortest-acting benzodiazepine receptor agonist? 1. Temazepam 2. Zolpidem 3. Zopiclone/eszopiclone 4. Clonazepam 5. Nitrazepam

11 Time profiles of plasma levels of some GABA-A PAMs taken at 23:00 Zaleplon** Zolpidem Zopiclone Temazepam liquid Temazepam tablet Nitrazepam Clonazepam 23:00 01:00 03:00 05:00 07:00 09:00 11:00 Time of day Darker blue represents higher plasma concentration

12 Longer-term studies with benzodiazepine receptor agonists Good evidence for maintained efficacy and safety in controlled studies of:- zolpidem (3-7 nights per week for 6 months) (Krystal et al 2008) eszopiclone nightly for 12 months (Roth et al 2005) zaleplon for 12 months in elderly (Ancoli-Israel et al 2005) These suggest dependence (tolerance/withdrawal) is not inevitable with hypnotic therapy up to 1 year, and is not characteristic of the several agents studied Stopping these drugs is more successful when patients have CBTi before and during the taper (Belleville et al 2007)

13 Histamine and sleep Histamine is one of the key wakefulness-maintaining neurotransmitters in the arousal system Histamine neurones in the hypothalamus fire prolifically in active waking, much less in quiet waking, and hardly at all during sleep Therefore antihistamines are unlikely exert their effect in sleep itself, but require activation of the histamine system to have their effect. They may promote quiet waking at the time of desired sleep and may also have effects to decrease short awakenings during sleep

14 Doxepin Doxepin is a drug with a tricyclic structure, used in depression. At antidepressant doses is a noradrenaline and serotonin reuptake inhibitor, and an antagonist at various brain receptors Its most potent action is as a histamine H1 antagonist Therefore at very low doses it will affect histamine receptors but have little effect at transporters or other brain receptors Low dose (3-6mg as opposed to antidepressant dose of ~100mg) licensed for insomnia in USA 4 good studies showing improvement in subjective amount of waking during the night

15 Melatonin Endogenous hormone secreted nightly in the pineal gland The hormone of darkness Exogenous melatonin brings sleep forward, ie when given in late evening reduces sleep latency Does not prolong sleep or reduce night-time awakenings Has no motor, memory or known hangover effects Very few side effects Prolonged release formulation marketed as a POM for the indication insomnia in adults aged >55, in whom it improves subjective sleep quality. (Clinical trials in adults conducted only in this age group) Also used in children with learning disability to aid settling at night

16 Individual drugs (efficacy in insomnia) Level 1b Significantly different from placebo Sleep onset latency PSG Total sleep time PSG Wake time after sleep onset Selfrated Selfrated Selfrated PSG Sleep quality Self-rated temazepam?? lormetazepam zopiclone zolpidem zaleplon eszopiclone PR melatonin

17 Hypersomnia (excessive daytime sleepiness, EDS) Apart from insufficient sleep and sleepiness at wrong time due to circadian rhythm disorder, 3 main disorders to treat 1) Obstructive sleep apnoea treated with physical means usually CPAP 2) Narcolepsy EDS and cataplexy symptoms treated with drugs 3) Idiopathic hypersomnia behavioural interventions and sometimes drugs

18 Which of these treatments used in narcolepsy does NOT improve cataplexy 1. Venlafaxine 2. Modafinil 3. Methylphenidate 4. Amphetamine 5. Fluoxetine

19 Hypersomnia (excessive daytime sleepiness, EDS) Usually treated at specialist sleep centres For EDS in narcolepsy, drugs used are: Modafinil, a dopamine uptake inhibitor Amphetamines* (dexamfetamine or lisdexamfetamine), dopamine and noradrenaline uptake inhibitors, dopamine and noradrenaline releasers Methylphenidate*, dopamine and noradrenaline uptake inhibitor, dopamine and noradrenaline releaser No drug is licensed for idiopathic hypersomnia, but the above are sometimes used as part of package including behavioral interventions Cataplexy in narcolepsy is often ameliorated by the starred stimulants above; it also can be treated with clomipramine, venlafaxine, fluoxetine or sodium oxybate. Sodium oxybate can also improve daytime sleepiness

20 Treating circadian rhythm disorders Consider lifestyle eg shift work, student sleep-wake habits Consider comorbid disorders eg schizophrenia, dementia If these are ruled out, delayed sleep phase syndrome is usually treated at a specialist sleep centre. Melatonin is effective in jet lag disorder, delayed sleep phase syndrome and free-running disorder, and light therapy is effective in delayed sleep-phase syndrome Precise timing of both of these is essential

21 More challenging circadian rhythm disorders Delayed sleep phase syndrome, non-24 sleep wake rhythm and irregular sleep wake rhythm are all common in psychosis. Behavioural treatment is recommended but not always possible In dementia, irregular sleep pattern and in particular troublesome behavior in the evening or night is a problem.

22 Which treatment should NOT be used in elderly patients with dementia to treat irregular sleep wake scheduling disorder? 1. Behavioural measures to increase daytime activity 2. Increased light levels in daytime 3. Decreased light at night 4. Sleep-promoting medication eg benzodiazepine receptor agonist or melatonin

23 Elderly people with dementia and sleep-wake rhythm disorder (ISWRD) Recommendations that clinicians treat ISWRD in elderly patients with dementia with light therapy (versus no treatment). [WEAK FOR] that clinicians avoid the use of sleep-promoting medications to treat demented elderly patients with ISWRD (versus no treatment). [STRONG AGAINST] that clinicians avoid the use of melatonin as a treatment for ISWRD in older people with dementia (versus no treatment). [WEAK AGAINST] that clinicians avoid the use of combined treatments consisting of light therapy in combination with melatonin in demented, elderly patients with ISWRD (versus no treatment). [WEAK AGAINST] AASM Task Force on circadian rhythm disorders. J Clin Sleep Med (10):

24 Restless legs syndrome Disorder of brain dopamine system, usually treated by a neurologist Strong evidence for involvement of Fe in brain, symptoms often ameliorated by treating low serum ferritin Unknown cause, but responds to dopaminergic drugs as in Parkinson s disease (rotigotine often used) RLS can be caused or made worse by many psychotropic drugs mirtazapine olanzapine sometimes serotonin reuptake inhibitors older histamine H1 antagonists older drugs used in depression eg amitriptyline, doxepin, probably because of H1 antagonism

25 Parasomnias Parasomnias most often treated are the non-rem parasomnias - night terrors and sleepwalking REM sleep behavior disorder

26 Which of these treatments has a good evidence base to treat non-rem parasomnias such as night terrors and sleepwalking? 1. Trazodone 2. Clonazepam 3. Paroxetine 4. Zopiclone 5. None of these

27 Parasomnias Non- REM parasomnias no controlled studies in adults Small studies and case series for Clonazepam Paroxetine Imipramine (RCT in children shows efficacy for 5HTP)

28 Do drugs cause sleepwalking? Case report evidence points to drugs provoking sleepwalking in a few people who have no previous history; sleepwalking resolves on stopping the drug 1 Most of these drugs are very sedating and with rapid effects zolpidem triazolam temazepam methaqualone sodium oxybate olanzapine thioridazine But also lithium paroxetine Often reports of taking night-time medication and not going to bed 1 Pressman 2007

29 Which of these drugs might you try in order to ameliorate REM behaviour disorder? 1. Mirtazapine 2. Venlafaxine 3. Melatonin 4. Citalopram

30 Parasomnias First focus of treatment should be safety of patient and bed partner Non- REM parasomnias Small studies and case series for Clonazepam Paroxetine Imipramine (RCT in children shows efficacy for 5HTP) REM sleep behavior disorder Melatonin Clonazepam

31 Drugs which probably provoke symptoms of REM behaviour disorder or make them worse mirtazapine all serotonin reuptake inhibitors venlafaxine duloxetine Not bupropion possibly imipramine, clomipramine (doubtful, no violent behaviours reported but high doses reduce REM atonia even in normals) bisoprolol tramadol Typically occurs within a few days of starting treatment or increasing dose

32 Bruxism (teeth-grinding) Can appear or be made worse during treatment with serotonin reuptake inhibitors / venlafaxine SRI-induced bruxism ameliorated by adding buspirone

Available Strengths Limits. 200 mg tablets PA. 50 mg, 150 mg, 200 mg, 250 mg tablets. 500 mg/ml solution PA

Available Strengths Limits. 200 mg tablets PA. 50 mg, 150 mg, 200 mg, 250 mg tablets. 500 mg/ml solution PA MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY Sleeping Disorders P&T DATE: 12/14/2016 THERAPEUTIC CLASS Psychiatric Disorders REVIEW HISTORY: 2/16, 5/15, 2/12 LOB AFFECTED

More information

Index. baclofen 73 basal forebrain nuclei 174

Index. baclofen 73 basal forebrain nuclei 174 Index acetazolamide 33 acetylcholine esterase inhibitor 174 actigraphy 14 activity meter 226 acute insomnia 4 α1 adrenergic activity 88 α 1 containing receptor 211 adenosine 108 advanced sleep phase syndrome

More information

Insomnia: Updates in Medical Management. Michael Newnam M.D.

Insomnia: Updates in Medical Management. Michael Newnam M.D. Insomnia: Updates in Medical Management Michael Newnam M.D. Sleep Neurobiology Delicate balance of excitatory and inhibitory neurotransmitters that control the switch between wakefulness and sleep Circadian

More information

Insomnia. Dr Terri Henderson MBChB FCPsych

Insomnia. Dr Terri Henderson MBChB FCPsych Insomnia Dr Terri Henderson MBChB FCPsych Plan Basics of insomnia Pharmacology Medication CBT Details of insomnia Unsatisfactory sleep that impairs daytime well-being Starts with specific problem or change

More information

Index. sleep.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. sleep.theclinics.com. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Actigraphy, 475, 485, 496 Adolescents, sleep disorders in, 576 578 Adults, sleep disorders in, 578 580 Advanced sleep phase disorder, 482 Age,

More information

SLEEP-WAKE DISORDERS: INSOMNIA. Prof. Paz Gía-Portilla

SLEEP-WAKE DISORDERS: INSOMNIA. Prof. Paz Gía-Portilla SLEEP-WAKE DISORDERS: INSOMNIA Prof. Paz Gía-Portilla SLEEP-WAKE DISORDERS AND ICD-10 Chapter V: Mental and Behavioural Disorders F51. Non-organic sleep disorders Chapter VI: Nervous System Illnesses G47.

More information

Recommended diagnosis and management of insomnia

Recommended diagnosis and management of insomnia n DRUG REVIEW Recommended diagsis and management of insomnia Sue Wilson PhD and David Nutt DM, FRCP, FRCPsych, FMedSci SPL Insomnia can cause impaired daytime functioning and reduced quality of life. In

More information

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic

More information

Insomnia: guide to diagnosis and recommended management

Insomnia: guide to diagnosis and recommended management Drug review : guide to diagsis and recommended management SPL Sue Wilson PhD and David Nutt DM, FRCP, FRCPsych, FMedSci is a major cause of distress due to fatigue and poor daytime performance. In our

More information

Insomnia % of adults suffer from chronic and severe insomnia (Complaints of insomnia with daytime consequences)

Insomnia % of adults suffer from chronic and severe insomnia (Complaints of insomnia with daytime consequences) 10-15% of adults suffer from chronic and severe insomnia (Complaints of insomnia with daytime consequences) 30 40% of adults complain of insomnia symptoms only 95% experience insomnia at some time in their

More information

Pharmacological Help for a Good Night s s Sleep. Thomas Owens, MD

Pharmacological Help for a Good Night s s Sleep. Thomas Owens, MD Pharmacological Help for a Good Night s s Sleep Thomas Owens, MD Objectives 1. Define insomnia and characterize the symptoms and array of causes. 2. Describe traditional and new pharmacologic approaches

More information

Drugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD

Drugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD Drugs, Sleep & Wakefulness Brian Koo Reena Mehra MD MS Kingman Strohl MD Things To Keep In Mind Many drugs effect sleep either causing insomnia or sedation Disruption of sleep and wakefulness may not be

More information

Insomnia treatment in primary care

Insomnia treatment in primary care Insomnia treatment in primary care Daniel J. Buysse, MD UPMC Professor of Sleep Medicine Professor of Psychiatry and Clinical and Translational Science University of Pittsburgh School of Medicine buyssedj@upmc.edu

More information

Ruby Williams, M.D. Drugs, Alcohol and Sleep February 24, 2018

Ruby Williams, M.D. Drugs, Alcohol and Sleep February 24, 2018 Ruby Williams, M.D. Drugs, Alcohol and Sleep February 24, 2018 Objectives Describe pharmacology of commonly prescribed drugs for stimulants and hypnotics Brief review of common drugs that affect sleep

More information

Insomnia. Learning Objectives. Disclosure 6/7/11. Research funding: NIH, Respironics, Embla Consulting: Elsevier

Insomnia. Learning Objectives. Disclosure 6/7/11. Research funding: NIH, Respironics, Embla Consulting: Elsevier Insomnia Teofilo Lee-Chiong MD Professor of Medicine National Jewish Health University of Colorado Denver School of Medicine Learning Objectives Learn about the causes of transient and chronic Learn how

More information

Individual Planning: A Treatment Plan Overview for Individuals Sleep Disorder Problems.

Individual Planning: A Treatment Plan Overview for Individuals Sleep Disorder Problems. COURSES ARTICLE - THERAPYTOOLS.US Individual Planning: A Treatment Plan Overview for Individuals Sleep Disorder Problems. Individual Planning: A Treatment Plan Overview for Individuals Sleep Disorder Problems.

More information

Modern Management of Sleep Disorders. If Only I Could Sleep Like I Did Before

Modern Management of Sleep Disorders. If Only I Could Sleep Like I Did Before Modern Management of Sleep Disorders Douglas C. Bauer, MD University of California, San Francisco No Disclosures If Only I Could Sleep Like I Did Before Sleep Case 52 yr. old WF with >4 yr. of poor sleep

More information

Sleep Disorders: Assessment and Therapeutic Options

Sleep Disorders: Assessment and Therapeutic Options Sleep Disorders: Assessment and Therapeutic Options John W. Winkelman MD, PhD Chief, Sleep Disorders Clinical Research Program Departments of Psychiatry and Neurology Massachusetts General Hospital Professor

More information

Insomnia Treatment in Brief

Insomnia Treatment in Brief Insomnia Treatment in Brief Project ECHO May 7, 2015 Jonathan Emens, M.D. Associate Professor, Departments of Psychiatry and Internal Medicine Oregon Health & Science University Staff Physician and Sleep

More information

Modern Management of Sleep Disorders. Case. Introduction. Topics Covered. Douglas C. Bauer, MD University of California, San Francisco

Modern Management of Sleep Disorders. Case. Introduction. Topics Covered. Douglas C. Bauer, MD University of California, San Francisco Modern Management of Sleep Disorders Douglas C. Bauer, MD University of California, San Francisco No Disclosures Case 68 yr. old WF with >15 yr. of poor sleep Difficulty with both initiation and maintenance

More information

PHARMACOLOGY OF SLEEP

PHARMACOLOGY OF SLEEP NAMS REGIONAL SYMPOSIUM ON SLEEP MEDICINE PHARMACOLOGY OF SLEEP DR. K.K. SHARMA Department of Pharmacology School of Medical Sciences & Research (SMSR) Sharda University, Greater Noida- 201306. 1 Introduction

More information

ADULT PRIMARY INSOMNIA

ADULT PRIMARY INSOMNIA Clinical Practice Guideline Adult Primary Insomnia: Diagnosis to Management 2007 Update This guideline was developed by a Clinical Practice Guidelines Working Group to assist physicians in the management

More information

A Review of Sleep Disorders in Cancer Patients: Finding the Dream Treatment

A Review of Sleep Disorders in Cancer Patients: Finding the Dream Treatment A Review of Sleep Disorders in Cancer Patients: Finding the Dream Treatment Jordan Pleskow, PharmD Roswell Park Cancer Institute Oncology Symposium 11/11/17 Objectives Evaluate the issues with sleep in

More information

Modern Management of Sleep Disorders

Modern Management of Sleep Disorders Modern Management of Sleep Disorders Douglas C. Bauer, MD University of California, San Francisco No Disclosures Case 68 yr. old WF with >15 yr. of poor sleep Difficulty with both initiation and maintenance

More information

DRUGS THAT ACT IN THE CNS

DRUGS THAT ACT IN THE CNS DRUGS THAT ACT IN THE CNS Anxiolytic and Hypnotic Drugs Dr Karamallah S. Mahmood PhD Clinical Pharmacology 1 OTHER ANXIOLYTIC AGENTS/ A. Antidepressants Many antidepressants are effective in the treatment

More information

Addressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling

Addressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling Addressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling Educational Objectives: At the completion of this knowledge-based activity, participants will be able to:

More information

Psychopharmacology of Sleep Disorders

Psychopharmacology of Sleep Disorders Psychopharmacology of Sleep Disorders John W. Winkelman MD, PhD Chief, Sleep Disorders Clinical Research Program Departments of Psychiatry and Neurology Massachusetts General Hospital Professor of Psychiatry

More information

Diagnosis and treatment of sleep disorders

Diagnosis and treatment of sleep disorders Diagnosis and treatment of sleep disorders Normal human sleep Sleep cycle occurs about every 90 minutes, approximately 4-6 cycles occur per major sleep episode NREM (70-80%) slow wave sleep heart rate,

More information

Dr Alex Bartle. Sleep Well Clinic

Dr Alex Bartle. Sleep Well Clinic Dr Alex Bartle Sleep Well Clinic Overview of Sleep Disorders Sleep: Why bother. Effect of Poor Quality or reduced Quantity of Sleep Common Sleep Disorders Management of Insomnia Medication vs CBTi Conclusion

More information

Insomnia. St. Joseph s Annual Family Practice Refresher March 1, Robert J. Ostrander, M.D

Insomnia. St. Joseph s Annual Family Practice Refresher March 1, Robert J. Ostrander, M.D St. Joseph s Annual Family Practice Refresher March 1, 2018 Robert J. Ostrander, M.D If in bed I say, When shall I arise? then the night drags on; I am filled with restlessness until the dawn. Job 7:4

More information

Earl J. Soileau, MD, FSAHM Asst Professor, Family Medicine LSU HSC Medical School New Orleans at Lake Charles

Earl J. Soileau, MD, FSAHM Asst Professor, Family Medicine LSU HSC Medical School New Orleans at Lake Charles Earl J. Soileau, MD, FSAHM Asst Professor, Family Medicine LSU HSC Medical School New Orleans at Lake Charles Sleep Disorders Restless Legs Syndrome (RLS) and Periodic Limb Movement Disorder (PLMD) Sleep

More information

Sleep disorders. Norbert Kozak

Sleep disorders. Norbert Kozak Sleep disorders Norbert Kozak About the sleep Each of us will spend about 1/3 of our lifetime sleeping....and 1/3 part of the population has sleep complain Sleep is an essential biological function, but

More information

14. Percent Mellinger GD et al. Arch Gen Psychiatry. 1985;42: ICSD III

14. Percent Mellinger GD et al. Arch Gen Psychiatry. 1985;42: ICSD III 4:45 5:45 pm Management of Insomnia and Other Disorders Presenter Disclosure Information The following relationships exist related to this presentation: Alon Y. Avidan, MD, MPH, FAAN, FAASM: Speakers Bureau

More information

TRAZODONE IN INSOMNIA COMORBID WITH DEPRESSION: AN AWAKENING LACK OF STRONG EVIDENCE

TRAZODONE IN INSOMNIA COMORBID WITH DEPRESSION: AN AWAKENING LACK OF STRONG EVIDENCE TRAZODONE IN INSOMNIA COMORBID WITH DEPRESSION: AN AWAKENING LACK OF STRONG EVIDENCE Gordon Ang, PharmD Central Texas Veterans Health Care System 1/5/2018 1 Abbreviations Abbreviation GERD MDD PTSD PSQI

More information

Chronic Insomnia: DSM - V. Insomnia DSM - V. Patient Symptoms. Insomnia: Assessment and Overview of Management. Insomnia Management in the Digital Age

Chronic Insomnia: DSM - V. Insomnia DSM - V. Patient Symptoms. Insomnia: Assessment and Overview of Management. Insomnia Management in the Digital Age Insomnia Management in the Digital Age Dr Anup Desai Sleep & Respiratory Medicine MBBS (syd), PhD (syd), FRACP Senior Staff Specialist, POW Hospital Medical Director, Sydney Sleep Centre Senior Lecturer,

More information

ALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY

ALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY ANTIDEPRESSANTS Serotonin Selective Reuptake Inhibitors citalopram 10, 20, 40 mg, 10 mg/5cc $ 0.40 No escitalopram 10, 20 mg $ 2.60 Yes fluoxetine 10, 20 mg, 20 mg/5 ml $ 0.40 Yes fluvoxamine 25, 50, 100

More information

DSM-5 INSOMNIA. Maintaining. Maintaining Sleep. Difficulty Falling Asleep: Difficulty. Early AM awakenings: (> 30 minutes before desired wake time)

DSM-5 INSOMNIA. Maintaining. Maintaining Sleep. Difficulty Falling Asleep: Difficulty. Early AM awakenings: (> 30 minutes before desired wake time) DSM-5 INSOMNIA 3 nights/wk 3 months Difficulty Falling Asleep: > 30 minutes Difficulty Maintaining Sleep Next Day Consequences Early AM awakenings: (> 30 minutes before desired wake time) Initiation Trouble

More information

Index 265. Feeding bottle, 37 methods, 37

Index 265. Feeding bottle, 37 methods, 37 Index 263 Index A Actigraphy delayed sleep phase syndrome, 66f Activity, 19 Adenoidectomy OSAHS, 121 Adolescents insomnia, 71 81 assessment and treatment, 76 78 etiology, 75, 76 female, 74, 75 sleep need

More information

SLEEP DISORDERS. Kenneth C. Sassower, MD Division of Sleep Medicine; Department of Neurology Massachusetts General Hospital for Children

SLEEP DISORDERS. Kenneth C. Sassower, MD Division of Sleep Medicine; Department of Neurology Massachusetts General Hospital for Children SLEEP DISORDERS Kenneth C. Sassower, MD Division of Sleep Medicine; Department of Neurology Massachusetts General Hospital for Children Distinctive Features of Pediatric Sleep Daytime sleepiness uncommon

More information

Question #1. Disclosures. CAPA 2015 Annual Conference. All of the following occur as we get older EXCEPT: Evaluating Patients with Insomnia

Question #1. Disclosures. CAPA 2015 Annual Conference. All of the following occur as we get older EXCEPT: Evaluating Patients with Insomnia Evaluating Patients with Roger D. Seheult, M.D. Pulmonary Critical Care Physician - Beaver Medical Group, Redlands California Assistant Clinical Professor of Medicine - Loma Linda University School of

More information

INSOMNIA IN THE GERIATRIC POPULATION. Shannon Bush, MS4

INSOMNIA IN THE GERIATRIC POPULATION. Shannon Bush, MS4 INSOMNIA IN THE GERIATRIC POPULATION Shannon Bush, MS4 CHANGES IN SLEEP ARCHITECTURE 2 Reduction in slow wave sleep (stage 3 and 4) Increase in lighter stages of sleep (stage 1 and 2) Decrease in REM sleep

More information

Objectives. Types of Sleep Problems in Developmental Disorders

Objectives. Types of Sleep Problems in Developmental Disorders Objectives Sleep Problems in the Child with Neurodevelopmental Disorders AACPDM September 11, 2014 BRK-3 Golda Milo-Manson MD, MHSc, FRCP(C) Holland Bloorview Kids Rehabilitation Hospital Toronto, Canada

More information

CPT David Shaha, MC US Army

CPT David Shaha, MC US Army CPT David Shaha, MC US Army None Thoughts and comments are my own and do not represent the official policy of the Department of the Army, Department of Defense, or United States Government. Clinical Case

More information

Insomnia Agents (Sherwood Employer Group)

Insomnia Agents (Sherwood Employer Group) Insomnia Agents (Sherwood Employer Group) BCBSKS will review Prior Authorization requests Prior Authorization Form: https://www.bcbsks.com/customerservice/forms/pdf/priorauth-6058ks-st-ippi.pdf Link to

More information

Dr Alex Bartle. Medical Director Sleep Well Clinic Christchurch

Dr Alex Bartle. Medical Director Sleep Well Clinic Christchurch Dr Alex Bartle Medical Director Sleep Well Clinic Christchurch 8:30-9:25 WS #191: Sleep Disorders in The Elderly 9:35-10:30 WS #203: Sleep Disorders in The Elderly (Repeated) REM - Rapid Eye Movement

More information

AGING CHANGES IN SLEEP

AGING CHANGES IN SLEEP OBJECTIVES: Understand the common age-related changes in sleep Discuss the evaluation of the older person with sleep complaints Identify sleep apnea, PLMS, RLS, and REM sleep disorders and their treatments

More information

OBJECTIVES. The psychiatric, medical, and neurologic causes of sleep problems. Office-based and objective methods of evaluating sleep

OBJECTIVES. The psychiatric, medical, and neurologic causes of sleep problems. Office-based and objective methods of evaluating sleep SLEEP ISSUES 1 OBJECTIVES 2 Know and understand: Age-related changes in sleep The psychiatric, medical, and neurologic causes of sleep problems Office-based and objective methods of evaluating sleep Appropriate

More information

HEALTHY LIFESTYLE, HEALTHY SLEEP. There are many different sleep disorders, and almost all of them can be improved with lifestyle changes.

HEALTHY LIFESTYLE, HEALTHY SLEEP. There are many different sleep disorders, and almost all of them can be improved with lifestyle changes. HEALTHY LIFESTYLE, HEALTHY SLEEP There are many different sleep disorders, and almost all of them can be improved with lifestyle changes. HEALTHY LIFESTYLE, HEALTHY SLEEP There are many different sleep

More information

Sleep and Circadian Rhythm Disorders diagnosis and management

Sleep and Circadian Rhythm Disorders diagnosis and management Sleep and Circadian Rhythm Disorders diagnosis and management Dr Kirstie Anderson Consultant Neurologist Regional Sleep Service Newcastle www.neurone.org/sleep-resources Bedtime stories how to take a sleep

More information

TOP 10 LIST OF SLEEP QUESTIONS. Kenneth C. Sassower, MD Sleep Disorders Unit Massachusetts General Hospital for Children

TOP 10 LIST OF SLEEP QUESTIONS. Kenneth C. Sassower, MD Sleep Disorders Unit Massachusetts General Hospital for Children TOP 10 LIST OF SLEEP QUESTIONS Kenneth C. Sassower, MD Sleep Disorders Unit Massachusetts General Hospital for Children QUESTION #1: ARE SLEEP ISSUES IN CHILDREN THE SAME AS IN ADULTS? Distinctive Features

More information

48 th Annual Meeting. Clinical Pearls: Depression, Insomnia and Bipolar Disorder DSM-5. Disclosure. Depression. Patient Case. Objectives 7/19/2014

48 th Annual Meeting. Clinical Pearls: Depression, Insomnia and Bipolar Disorder DSM-5. Disclosure. Depression. Patient Case. Objectives 7/19/2014 48 th Annual Meeting Clinical Pearls: Depression, Insomnia and Bipolar Disorder DSM-5 Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Published in 2013 Most published treatment guidelines

More information

Overview. Sleep Related Movement Disorders - Restless Leg Syndrome - Periodic Limb movements in Sleep

Overview. Sleep Related Movement Disorders - Restless Leg Syndrome - Periodic Limb movements in Sleep The Structure of Sleep The Parasomnias - in REM - in Non-REM - Narcolepsy Overview Sleep Related Movement Disorders - Restless Leg Syndrome - Periodic Limb movements in Sleep Circadian Rhythm disorders

More information

Managing Sleep Disorders in Primary Care. Objectives. Disclosures. Nancy Nadolski, FNP, MSN, M.Ed Insomnia Medicine of Idaho Boise Counseling Center

Managing Sleep Disorders in Primary Care. Objectives. Disclosures. Nancy Nadolski, FNP, MSN, M.Ed Insomnia Medicine of Idaho Boise Counseling Center Managing Sleep Disorders in Primary Care Nancy Nadolski, FNP, MSN, M.Ed Insomnia Medicine of Idaho Boise Counseling Center www.sleeplessinidaho.com 1 Objectives 1) Identify stages and behaviors for normal

More information

Psychotropic Medication Use in Dementia

Psychotropic Medication Use in Dementia Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,

More information

Anxiolytic and Hypnotic drugs

Anxiolytic and Hypnotic drugs Anxiolytic and Hypnotic drugs Anxiolytic and Hypnotic drugs Anxiety is unpleasant state of tension and fear that seems to arise from unknown source. The symptoms of severe anxiety are similar to those

More information

South London and the Maudsley NHS Foundation Trust Medicines Formulary

South London and the Maudsley NHS Foundation Trust Medicines Formulary South London and the Maudsley NHS Foundation Trust Medicines Formulary Medicine Formulations Restrictions Additional Information / Related NICE Technology Appraisal 4.1 Hypnotics and anxiolytics 4.1.1

More information

Definitions. Prevalence. Chronic Insomnia DSM-5 INSOMNIA. Insomnia Is a Distinct Disorder That Should Be Treated ~10% 3 nights/wk 3 months

Definitions. Prevalence. Chronic Insomnia DSM-5 INSOMNIA. Insomnia Is a Distinct Disorder That Should Be Treated ~10% 3 nights/wk 3 months Chronic Definitions Alon Y. Avidan, M.D., M.P.H UCLA Sleep Disorders Center Is a Distinct Disorder That Should Be Treated NIH (1983) 1 NIH (2005) 2 is a symptom, is a disorder not a disorder DSM-5 INSOMNIA

More information

일차진료에서불면증치료 김종우. Primary Insomnia : DSM-IV criteria 경희대학교의과대학정신과학교실 MEMO. Diagnostic Criteria for Insomnia (ICSD-2) 개원의와함께하는임상강좌

일차진료에서불면증치료 김종우. Primary Insomnia : DSM-IV criteria 경희대학교의과대학정신과학교실 MEMO. Diagnostic Criteria for Insomnia (ICSD-2) 개원의와함께하는임상강좌 개원의와함께하는임상강좌 2011 일차진료에서불면증치료 경희대학교의과대학정신과학교실 김종우 Diagnostic Criteria for Insomnia (ICSD-2) International Classification of Sleep Disorders, 2nd Edition (ICSD-2) Primary Insomnia : DSM-IV criteria A. The

More information

14. Percent

14. Percent 4:30 5:45 pm Management of Insomnia and Other Disorders Presenter Disclosure Information The following relationships exist related to this presentation: Alon Y. Avidan, MD, MPH, FAAN, FAASM: Speakers Bureau

More information

Primary efficacy Sleep measures in insomnia SLEEP IS NECESSARY FOR:1,2

Primary efficacy Sleep measures in insomnia SLEEP IS NECESSARY FOR:1,2 Primary efficacy Sleep measures in insomnia SLEEP IS NECESSARY FOR:1,2 Insomnia Insomnia is a condition of unsatisfactory sleep, either in terms of sleep onset, sleep maintenance or early waking.3 Insomnia

More information

CHALLENGES OF RECOGNIZING AND TREATING EXCESSIVE SLEEPINESS

CHALLENGES OF RECOGNIZING AND TREATING EXCESSIVE SLEEPINESS CHALLENGES OF RECOGNIZING AND TREATING EXCESSIVE SLEEPINESS Russell Rosenberg, Ph.D. Neurotrials Research and Atlanta School of Sleep Medicine DISCLOSURES Research grant funds from: Merck Jazz Pharmaceuticals

More information

Guideline for Adult Insomnia

Guideline for Adult Insomnia Guideline for Adult Insomnia Exclusions This guideline does not apply to: Children under the age of 18 Pregnant and lactating women Geriatric patients: While the general principles of the diagnosis and

More information

MMG003 GUIDELINES FOR THE USE OF HYPNOTICS FOR THE TREATMENT OF INSOMNIA

MMG003 GUIDELINES FOR THE USE OF HYPNOTICS FOR THE TREATMENT OF INSOMNIA MMG003 GUIDELINES FOR THE USE OF HYPNOTICS FOR THE TREATMENT OF INSOMNIA Page 1 of 11 Table of Contents Why we need this Guideline... 3 What the Policy is trying to do... 3 Which stakeholders have been

More information

Anxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Anxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Anxiolytic, Sedative and Hypnotic Drugs Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Anxiolytics: reduce anxiety Sedatives: decrease activity, calming

More information

Parkinson s Disease Associated Sleep Disturbance Ehsan M. Hadi, MD, MPH. Dignity Health Neurological Institute

Parkinson s Disease Associated Sleep Disturbance Ehsan M. Hadi, MD, MPH. Dignity Health Neurological Institute Parkinson s Disease Associated Sleep Disturbance Ehsan M. Hadi, MD, MPH. Dignity Health Neurological Institute Parkinson s Disease 2 nd most common neurodegenerative disorder Peak age at onset is 60 years

More information

Learning Objectives. Management of Insomnia. Impact of Chronic Insomnia. Insomnia: Definitions. Measurement of Goals. Goals of Therapy 9/29/2017

Learning Objectives. Management of Insomnia. Impact of Chronic Insomnia. Insomnia: Definitions. Measurement of Goals. Goals of Therapy 9/29/2017 Learning Objectives Characterize insomnia and its negative effects Management of Insomnia Discuss the goals of treatment Summarize guidelines of management of insomnia including non-pharmacologic and pharmacologic

More information

Sleep Disorders in the Psychiatric Context

Sleep Disorders in the Psychiatric Context Sleep Disorders in the Psychiatric Context John W. Winkelman MD, PhD Chief, Sleep Disorders Clinical Research Program Departments of Psychiatry and Neurology Massachusetts General Hospital Associate Professor

More information

Sleep, tiredness, lack of energy: heart sink symptoms

Sleep, tiredness, lack of energy: heart sink symptoms Sleep, tiredness, lack of energy: heart sink symptoms Abstract Problematic sleep is a widespread issue and insomnia is the commonest complaint. The diagnosis of insomnia requires thorough history-taking

More information

What is sleep? o Sleep is a body s rest cycle.

What is sleep? o Sleep is a body s rest cycle. What is sleep? o Sleep is a state when our senses and motor actvity are relatively suspended; there is a total or partial unconsciousness and all voluntary muscles are inactive. o Sleep is a body s rest

More information

Sleep and Parkinson's Disease

Sleep and Parkinson's Disease Parkinson s Disease Clinic and Research Center University of California, San Francisco 505 Parnassus Ave., Rm. 795-M, Box 0114 San Francisco, CA 94143-0114 (415) 476-9276 http://pdcenter.neurology.ucsf.edu

More information

Sleep Disorders. Anneka Rose ST5 Psychiatrist

Sleep Disorders. Anneka Rose ST5 Psychiatrist Sleep Disorders Anneka Rose ST5 Psychiatrist Agenda Basic overview of sleep structure Interactive case based discussions 5 min interventions MCQs Questions Hypnogram Actigraphy Common Scenario Patient

More information

Index. sleep.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. sleep.theclinics.com. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Accidents, risk of, with insufficient sleep, 318 Acquired immunodeficiency syndrome (AIDS), comorbid with narcolepsy, 298 299 Actigraphy, in

More information

Sleep and Students. John Villa, DO Medical Director

Sleep and Students. John Villa, DO Medical Director Sleep and Students John Villa, DO Medical Director Objectives: Importance and Benefits of Sleep States and Stages of the Sleep Cycle Sleep Needs, Patterns and Characteristics for All Ages Healthy Sleep

More information

Facts about Sleep. Circadian rhythms are important in determining human sleep patterns/ sleep-waking cycle

Facts about Sleep. Circadian rhythms are important in determining human sleep patterns/ sleep-waking cycle Sleep Sleep is described as a state of unconsciousness or partial consciousness from which a person can be roused by stimulation Period of rest and recovery People spend about a third of their lives sleeping

More information

Sleep Disorders. Hugh Selsick

Sleep Disorders. Hugh Selsick Sleep Disorders Hugh Selsick Obstructive Sleep Apnoea What it is: Repeated narrowing or collapse of the upper airway during sleep. Leads to choking, oxygen desaturations and repeated arousals. Physical

More information

Sleep Disorders. Guidance for Primary Care. National Advisory Group for Respiratory Managed Clinical Networks

Sleep Disorders. Guidance for Primary Care. National Advisory Group for Respiratory Managed Clinical Networks Sleep Disorders Guidance for Primary Care National Advisory Group for Respiratory Managed Clinical Networks Presentation Patient complaining of difficulty sleeping, ongoing fatigue, poor concentration

More information

Nikolaus C. Netzer MD Hermann Buhl Institute for Hypoxia and Sleep Medicine Research, Bad Aibling Paracelsus Medical University, Salzburg, Austria

Nikolaus C. Netzer MD Hermann Buhl Institute for Hypoxia and Sleep Medicine Research, Bad Aibling Paracelsus Medical University, Salzburg, Austria Hypersomnolonce in Non-SAHS Patients Nikolaus C. Netzer MD Hermann Buhl Institute for Hypoxia and Sleep Medicine Research, Bad Aibling Paracelsus Medical University, Salzburg, Austria Definitions of Hypersomnolence

More information

Overview. Surviving shift work. What is the circadian rhythm? Components of a Generic Biological Timing System 31/10/2017

Overview. Surviving shift work. What is the circadian rhythm? Components of a Generic Biological Timing System 31/10/2017 Overview Surviving shift work Dr Claire M. Ellender Respiratory and Sleep Physician Princess Alexandra Hospital Conflicts nil relevant Circadian rhythm Impacts of shift work on health Case example Circadian

More information

John McLachlan. Clinical Lead Pulmonary Physiology & Sleep Medicine. President Elect, WA Branch Thoracic Society of Australia & NZ

John McLachlan. Clinical Lead Pulmonary Physiology & Sleep Medicine. President Elect, WA Branch Thoracic Society of Australia & NZ John McLachlan Respiratory & Sleep Physician @FSH Clinical Lead Pulmonary Physiology & Sleep Medicine Sleep Physician x 27 years Interest in Insomnia management President Elect, WA Branch Thoracic Society

More information

Pharmacy Benefit Determination Policy

Pharmacy Benefit Determination Policy Policy Subject: CNS Stimulant Medications Policy Number: SHS PBD06 Category: CNS Drugs Policy Type: Medical Pharmacy Department: Pharmacy Product (check all that apply): Group HMO/POS ASO PPO Individual

More information

Insomnia Management Guideline

Insomnia Management Guideline Insomnia Management Guideline Guideline Development This document is an update of existing guidance and has been developed by Barnsley CCG Medicines Management Team in consultation with colleagues from

More information

WHY CAN T I SLEEP? Deepti Chandran, MD

WHY CAN T I SLEEP? Deepti Chandran, MD WHY CAN T I SLEEP? Deepti Chandran, MD Sleep and Aging How does sleep change as we age? Do we need less sleep as we get older? Can a person expect to experience more sleep problems or have a sleep disorder

More information

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral

More information

Insomnia: habits, help, and hazards

Insomnia: habits, help, and hazards Insomnia: habits, help, and hazards Balanced data about medications www.rxfacts.org Copyright 2010 by The Alosa Foundation www.rxfacts.org November 2010 2 www.rxfacts.org Author: Leslie Jackowski, B.Sc.,

More information

Benzodiazepines and Hypnotics

Benzodiazepines and Hypnotics Benzodiazepines and Hypnotics Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if Trust wide): Review date (when this version goes out of date):

More information

Sleep and Insomnia 2/8/2018. Presented by. Marie Rataj, MSN, APRN, ANP. Objectives. Everything you wanted to know

Sleep and Insomnia 2/8/2018. Presented by. Marie Rataj, MSN, APRN, ANP. Objectives. Everything you wanted to know Sleep and Insomnia Everything you wanted to know Presented by Marie Rataj, MSN, APRN, ANP Objectives Develop a basic knowledge of normal sleep and differentiate from abnormal sleep Develop basic understanding

More information

Psychopharmacology of Sleep Disorders

Psychopharmacology of Sleep Disorders Psychopharmacology of Sleep Disorders Matt T. Bianchi MD PhD MMSc Assistant Professor Director, Sleep Division Neurology Department Massachusetts General Hospital Funding and Disclosures Funding: MGH Neurology

More information

Any interventions, where RCTs in PD are not available, are not included in the tables.

Any interventions, where RCTs in PD are not available, are not included in the tables. Tables Interventions where new studies have been published are indicated in bold italics. Changes in conclusions are indicated in italics and are highlighted in yellow. Any interventions, where RCTs in

More information

Mentoring Session: Participant Cases

Mentoring Session: Participant Cases Handout for the Neuroscience Education Institute (NEI) online activity: Mentoring Session: Participant Cases The Case: 55-year-old patient with depression and anxiety The Question: What to do when antidepressants

More information

Sleep This factsheet is available in a downloadable PDF here. Table of Contents Introduction Insomnia How Long does Insomnia Last? How much Sleep should You get? Symptoms of Insomnia Causes of Insomnia

More information

Managing Insomnia Disorder A Review of the Research for Adults

Managing Insomnia Disorder A Review of the Research for Adults Managing Insomnia Disorder A Review of the Research for Adults e Is This Information Right for Me? This information is right for you if: Your health care professional said you have insomnia disorder (said

More information

Use of Psychotropic Medications in Older Adults with Dementia!

Use of Psychotropic Medications in Older Adults with Dementia! Use of Psychotropic Medications in Older Adults with Dementia! Deepa Pattani, PharmD, RPh Owner: PrevInteract Health Deepa.Pattani@PrevInteract.com 972-372-9775 About Me Deepa Pattani, PharmD, RPh with

More information

Summary of the risk management plan (RMP) for Wakix (pitolisant)

Summary of the risk management plan (RMP) for Wakix (pitolisant) EMA/794885/2015 Summary of the risk management plan (RMP) for Wakix (pitolisant) This is a summary of the risk management plan (RMP) for Wakix, which details the measures to be taken in order to ensure

More information

Objectives. Sleep Problems in the Child with Physical Disabilities AACPDM September 14, Types of Sleep Problems

Objectives. Sleep Problems in the Child with Physical Disabilities AACPDM September 14, Types of Sleep Problems Sleep Problems in the Child with Physical Disabilities AACPDM September 14, 2017 Golda Milo-Manson MD, MHSc, FRCP(C) Holland Bloorview Kids Rehabilitation Hospital Toronto, Canada Objectives Current evidence

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Abuse sleep physiology effects of, 880 882 substance, in adolescents, sleep problems and, 929 946. See also Substance use and abuse, in adolescents,

More information

Introduction to Drug Treatment

Introduction to Drug Treatment Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical

More information

Dr Alex Bartle. Medical Director Sleep Well Clinic Christchurch

Dr Alex Bartle. Medical Director Sleep Well Clinic Christchurch Dr Alex Bartle Medical Director Sleep Well Clinic Christchurch 11:00-11:55 WS #113: Circadian Sleep Disorders 12:05-13:00 WS #125: Circadian Sleep Disorders (Repeated) Overview The Structure of Sleep

More information

Sleep in Children and Teens: Medical Aspects

Sleep in Children and Teens: Medical Aspects Sleep in Children and Teens: Medical Aspects Dr. Hazen Gandy, M.D., FRCP (C) Psychiatrist Hub Specialist, Project ECHO Ontario Child and Youth Mental Health Tuesday, November 27, 2018 Faculty and/or presenter

More information

Hypersomnolence. Fang Han MD Nikolas Netzer MD PhD June 2013

Hypersomnolence. Fang Han MD Nikolas Netzer MD PhD June 2013 Hypersomnolence Fang Han MD Nikolas Netzer MD PhD June 2013 Definitions of Hypersomnolence (DSM IV, AASM, ICSD) Real hypersomnia: Hypersomnolence is measurable with a positive MSLT and ESS score, sleep

More information

Disclosure. Sleep Medications in Primary Care: How to choose, what to avoid

Disclosure. Sleep Medications in Primary Care: How to choose, what to avoid Sleep Medications in Primary Care: How to choose, what to avoid Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP President, Fitzgerald Health Education Associates, North Andover,

More information